bioT3 Metastatic Cancer Solution

bioT3 is a set of diagnostic and therapeutic insights across the continuum of metastatic cancer management. These bioT3 assays deliver the right information at the right time to help patients receive the right therapy:

  • CancerTYPE ID® – Molecular classification for definitive diagnosis of tumor type and subtype
  • CancerTARGET ID – (Formerly PRÉCIS®) Actionable tumor-specific biomarkers for the selection of on-label targeted therapies
  • CancerTREATMENT ID – Next Generation Sequencing (NGS) + multi-platform biomarkers for comprehensive treatment options

CancerTYPE ID      CancerTYPE ID      CancerTARGET ID